Posted By
Tags
- 1A
- 2025
- 22nd century
- 3
- A
- ACCE
- Achievement
- Acro
- Across
- Acute
- Acute exacerbation
- Adherence
- Adolescence
- Adolescent girls
- Adolescents
- Adult
- Africa
- Ageing
- AIDS
- Alone
- An
- Analyse
- Analysis
- Appropriation
- Approved
- Around the World
- Ask
- At Risk
- Bachelor of Medicine, Bachelor of Surgery
- Based on
- Behavior
- Being
- Bekker
- Benefit
- Biology
- Birth
- Blinded
- Blinded experiment
- Bolster
- Brazil
- Broad
- Calif
- Cape
- Cape Town
- Capsid
- Challenge
- Challenges
- Chief
- Chief Medical Officer
- Choice
- Cisgender
- Clinical
- Clinical endpoint
- Clinical program
- Clinical trial
- Clinical Trials
- Collaboration
- Commitment
- Communities
- Communities affected
- Community
- Community engagement
- Comparator
- Complete
- Comprehensive
- Comprise
- Concern
- Condom
- Condom use
- Conduct
- Conducting
- Consensus
- Consistency
- Containment
- Continuing
- Contraindication
- Correctness
- Critical
- Data
- Data monitoring
- Data monitoring committee
- Demonstration
- Description
- Design community
- Desmond Tutu
- Determined
- Diagnosis
- Diagnosis of HIV/AIDS
- Discontinuation
- Discontinued products
- Discrimination
- Diverse
- DMC
- Doctor of Medicine
- Dosing
- Drug
- Drug resistance
- Drugs
- DTM&H
- Efficacy
- Efficacy endpoint
- Efficacy endpoints
- Emerge
- Emtricitabine
- Emtricitabine/tenofovir
- Enabling
- End
- End-of-life
- Endpoint
- Endpoints
- Engagement
- Epidemic
- Epidemiology
- Epidemiology of HIV/AIDS
- Ethics
- Every
- Exacerbation
- Expect
- Exposure
- Face
- Factor
- Fatigue
- FDA
- Fever
- Field
- Filing
- First Data
- Fit
- Fits
- Five
- Following
- Follow-up
- Food and Drug Administration
- Foster
- Foster City, California
- FTC
- Fumaric acid
- Gender
- Genderqueer
- Gild
- Gilead
- Gilead Sciences
- Girls
- Goal
- Having
- HBV
- Health
- Helping behavior
- Hepatitis
- Hepatitis B
- Hepatitis B virus
- Herpes B virus
- HIV
- HIV/AIDS
- Hiv incidence
- Hiv prevention research
- Human sexual activity
- Identified
- If
- Impact
- Implement
- Incidence
- Include
- Includes
- Inclusion
- Indication
- Infected
- Infection
- Inhibitor
- Initiate
- Initiation
- Injection
- Innovation
- Input
- Instrumental
- Intention
- Interim
- Interim analysis
- International
- International AIDS Society
- Kind of
- Laboratory
- Landmark
- Light
- Limitation
- Liver
- Male
- Man-hour
- M.D.
- MD–PhD
- Medical
- Medical Officer
- Men
- Mesame Dasi
- Mexico
- Milestone
- Monitor
- Monitoring
- Most
- Myalgia
- NASDAQ
- Need
- Negative
- Network
- New
- No
- Nokia 5300
- Numerical analysis
- Obligatio consensu
- Officer
- Only
- Open-label trial
- Option
- Options
- Oral Pill
- Oral Prep
- Over
- Participant recruitment
- Participation
- Partner
- Partnering
- Partners
- Persistence
- Personal identity
- Peru
- Phase
- Phase 3
- PHD
- Pill
- Pivotal
- Pivotal trial
- Placebo
- Planning
- Population
- Positive
- Pre-exposure prophylaxis
- Prep
- Prescription
- Presenting
- Prevention
- Prevention measures
- Prevention of HIV/AIDS
- Primary
- Product
- Prophylaxis
- Randomized controlled trial
- Randomness
- Rangefinder
- Recognize
- Recommended
- Recruitment
- Recruitment strategies
- Reduce
- Regimen
- Regions
- Regulation
- Regulatory authorities
- Research
- Resistance
- Result
- Risk
- Risk factor
- Safe
- Safer
- Safer sex practices
- Safe sex
- Safety
- Safety concerns
- Safety information
- Science
- Secondary
- Sensor
- Series and parallel circuits
- Severity
- Sex
- Sexual
- Sexual intercourse
- Sexually transmitted infection
- Sexually Transmitted Infections
- Sexual partner
- Signs
- Signs and symptoms of HIV/AIDS
- Sites
- Skin
- Some
- Some People
- Sophie Labelle
- South Africa
- Statistics
- STI
- Stigma
- Stigma and discrimination
- Sti prevention
- Storing
- Strategy
- Subcutaneous
- Substitution
- Subtypes of HIV
- Superior
- Superiority
- Symptom
- Symptoms
- TDF
- Tenofovir alafenamide
- Tenofovir disoproxil
- Tested
- Tests
- The Blinded
- The Drugs
- The first
- The independent
- The international
- Therapy
- The trial
- The world
- Third
- Three
- Today
- Town
- Traditional
- Transgender
- Trans man
- Transmitter
- Trans woman
- Treating
- Trial
- Trial design
- Trials
- Triple Zero
- Uganda
- Underrepresented
- Undetected
- University
- University of Cape Town
- Unknown
- Vagina
- Variant
- Warning
- Warnings
- When
- Who
- Women
- Women in
- Zero